|
1
|
Legro RS, Kunselman AR, Dodson WC and
Dunaif A: Prevalence and predictors of risk for type 2 diabetes
mellitus and impaired glucose tolerance in polycystic ovary
syndrome: a prospective, controlled study in 254 affected women. J
Clin Endocrinol Metab. 84:165–169. 1999.PubMed/NCBI
|
|
2
|
Hu G, Qiao Q, Tuomilehto J, Balkau B,
Borch-Johnsen K and Pyorala K; DECODE Study Group: Prevelence of
the metabolic syndrome and its relation to all-cause and
cardiovascular mortality in nondiabetic European men and women.
Arch Intern Med. 164:1066–1076. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Boura-Halfon S and Zick Y: Phosphorylation
of IRS proteins, insulin action, and insulin resistance. Am J
Physiol Endocrinol Metab. 296:E581–E591. 2009. View Article : Google Scholar
|
|
4
|
Coviello AD, Legro RS and Dunaif A:
Adolescent girls with polycystic ovary syndrome have an increased
risk of the metabolic syndrome associated with increasing androgen
levels independent of obesity and insulin resistance. J Clin
Endocrinol Metab. 91:492–497. 2006. View Article : Google Scholar
|
|
5
|
Banaszewska B, Pawelczyk L, Spaczynski RZ,
Dziura J and Duleba AJ: Effects of simvastatin and oral
contraceptive agent on polycystic ovary syndrome: prospective,
randomized, crossover trial. J Clin Endocrinol Metab. 92:456–461.
2007. View Article : Google Scholar
|
|
6
|
Ibáñez L, Jaramillo AM, Ferrer A and de
Zegher F: High neutrophil count in girls and women with
hyperinsulinaemic hyperandrogenism: normalization with metformin
and flutamide overcomes the aggravation by oral contraception. Hum
Reprod. 20:2457–2462. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
González F, Rote NS, Minium J and Kirwan
JP: In vitro evidence that hyperglycemia stimulates tumor necrosis
factor-alpha release in obese women with polycystic ovary syndrome.
J Endocrinol. 188:521–529. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Tataranni PA and Ortega E: A burning
question: does an adipokine-induced activation of the immune system
mediate the effect of overnutrition on type 2 diabetes? Diabetes.
54:917–927. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lumeng CN and Saltiel AR: Inflammatory
links between obesity and metabolic disease. J Clin Invest.
121:2111–2117. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
10
|
Nicklas BJ, Ambrosius W, Messier SP, et
al: Diet-induced weight loss, exercise, and chronic inflammation in
older, obese adults: a randomized controlled clinical trial. Am J
Clin Nutr. 79:544–551. 2004.PubMed/NCBI
|
|
11
|
Mohamed-Ali V, Goodrick S, Rawesh A, et
al: Subcutaneous adipose tissue releases interleukin-6, but not
tumour necrosis factor-alpha, in vivo. J Clin Endocrinol Metab.
82:4196–4200. 1997.PubMed/NCBI
|
|
12
|
Lagathu C, Bastard JP, Auclair M, Maachi
M, Capeau J and Caron M: Chronic interleukin (IL-6) treatment
increased IL-6 secretion and induced insulin resistance in
adipocyte: prevetion by rosigilitazone. Biochem Biophys Res Commun.
311:372–379. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Homaidan FR, Chakroun I and El-Sabban ME:
Regulation of nuclear factor-kappaB in intestinal epithelial cells
in a cell model inflammation. Mediators Inflamm. 12:277–283. 2003.
View Article : Google Scholar
|
|
14
|
Shoelson SE, Lee J and Goldfine AB:
Inflammation and insulin resistance. Clin Invest. 116:1793–1801.
2006. View
Article : Google Scholar
|
|
15
|
Ognjanovic S, Jacobs DR, Steinberger J,
Moran A and Sinako AR: Relation of chemokines to BMI and insulin
resistance at ages 18–21. Int J Obes (Lond). 37:420–423. 2013.
View Article : Google Scholar
|
|
16
|
Gerhardt CC, Romero IA, Cancello R, Camoin
L and Strosberg AD: Chemokines control fat accumulation and leptin
secretion by cultured human adipocytes. Mol Cell Endocrinol.
175:81–92. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Takahashi K, Mizuarai S, Araki H, et al:
Adipocity elevates plasma MCP-1 levels leading to the increased
CD11b-positive monocytes in mice. J Biol Chem. 278:46654–46660.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kershaw EE and Flier JS: Adipose tissue as
an endocrine organ. J Clin Endocrinol Metab. 89:2548–2556. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Hsiung SC, Tamir H, Franke TF and Liu KP:
Roles of extracellular signal-regulated kinase and Akt signaling in
coordinating nuclear transcription factor-kappaB-dependent cell
survival after serotonin 1A receptor activation. J Neurochem.
95:1653–1666. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kaidashev IP: Activation of NF-κB under
metabolic syndrome. Internationl J Physiol Pathophysiol. 3:287–297.
2012. View Article : Google Scholar
|
|
21
|
Suganami T, Tanimoto-Koyama K, Nishida J,
et al: Role of the toll-like receptor 4/NF-kappaB pathway in
saturated fatty acid-induced inflammatory changes in the
interaction between adipocytes and macrophages. Arterioscler Thromb
Vasc Biol. 27:84–91. 2007. View Article : Google Scholar
|
|
22
|
Kovacheva EL, Hikim AP, Shen R, Sinha I
and Sinha-Hikim I: Testosterone supplementation reverses sarcopenia
in aging through regulation of myostatin, c-Jun NH2-terminal
kinase, notch, and Akt signaling pathways. Endocrinology.
151:628–638. 2010. View Article : Google Scholar :
|
|
23
|
Sun HZ, Yang TW, Zang WJ and Wu SF:
Dehydroepiandrosterone-induced proliferation of prostatic
epithelial cell is mediated by NFKB via PI3K/AKT signaling pathway.
J Endocrinol. 204:311–318. 2010. View Article : Google Scholar
|
|
24
|
Wu Y, Bauman WA, Blitzer RD and Cardozo C:
Testosterone- induced hypertrophy of L6 myoblasts is dependent upon
Erk and mTOR. Biochem Biophys Res Commun. 400:679–683. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Yamamoto Y, Yoshimasa Y, Koh M, et al:
Constitutively active mitogen-activated protein kinase kinase
increases GLUT1 expression and recruits both GLUT1 and GLUT4 at the
cell surface in 3T3-L1 adipocytes. Diabetes. 49:332–339. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Yin J, Zuberi A, Gao Z, Liu D, Liu Z and
Ye J: Shilianhua extract inhibits GSK-3beta and promotes glucose
metabolism. Am J Physiol Endocrinol Metab. 296:E1275–E1280. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Benson S, Janssen OE, Hahn S, et al:
Obesity, depression, and chronic low-grade inflammation in women
with polycystic ovary syndrome. Brain Behav Immun. 22:177–184.
2008. View Article : Google Scholar
|
|
28
|
Marino JS, Iler J, Dowling AR, et al:
Adipocyte dysfunction in a mouse model of polycystic ovary syndrome
(PCOS): evidence of adipocyte hypertrophy and tissue-specific
inflammation. PLoS One. 7:e486432012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Greenberg AS and Obin MS: Obesity and the
role of adipose tissue in inflammation and metabolism. Am J Clin
Nutr. 83:461S–465S. 2006.PubMed/NCBI
|
|
30
|
Lei Y, Zhang Y, Cao Y, et al:
Up-regulation of bradykinin receptors in rat bronchi via I kappa B
kinase-mediated inflammatory signaling pathway. Eur J Pharmacol.
634:149–161. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Corbould A, Zhao H, Mirzoeva S, Aird F and
Dunaif A: Enhanced mitogenic signaling in skeletal muscle of women
with polycystic ovary syndrome. Diabetes. 55:751–759. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
González F, Rote NS, Minium J and Kirwan
JP: Increased activation of nuclear factor kappaB triggers
inflammation and insulin resistance in polycystic ovary syndrome. J
Clin Endocrinol Metab. 91:1508–1512. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Yeung YT, Bryce NS, Adams S, et al: p38
MAPK inhibitors attenuate pro-inflammatory cytokine production and
the inva-siveness of human U251 glioblastoma cells. J Neurooncol.
109:35–44. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Tan BK, Adya R, Chen J, et al: Metformin
decreases angiogenesis via NF-kappaB and Erk1/2/Erk5 pathways by
increasing the antiangiogenic thrombospondin-1. Cardiovasc Res.
83:566–574. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
González F, Nair KS, Daniels JK, Basal E
and Schimke JM: Hyperandrogenism sensitizes mononuclear cells to
promote glucose-induced inflammation in lean reproductive-age
women. Am J Physiol Endocrinol Metab. 302:E297–E306. 2012.
View Article : Google Scholar :
|
